1. Home
  2. TOI vs HFRO^B Comparison

TOI vs HFRO^B Comparison

Compare TOI & HFRO^B Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOI
  • HFRO^B
  • Stock Information
  • Founded
  • TOI 2007
  • HFRO^B N/A
  • Country
  • TOI United States
  • HFRO^B United States
  • Employees
  • TOI N/A
  • HFRO^B N/A
  • Industry
  • TOI Medical/Nursing Services
  • HFRO^B
  • Sector
  • TOI Health Care
  • HFRO^B
  • Exchange
  • TOI Nasdaq
  • HFRO^B Nasdaq
  • Market Cap
  • TOI 266.8M
  • HFRO^B N/A
  • IPO Year
  • TOI N/A
  • HFRO^B N/A
  • Fundamental
  • Price
  • TOI $3.19
  • HFRO^B N/A
  • Analyst Decision
  • TOI
  • HFRO^B
  • Analyst Count
  • TOI 0
  • HFRO^B 0
  • Target Price
  • TOI N/A
  • HFRO^B N/A
  • AVG Volume (30 Days)
  • TOI 1.7M
  • HFRO^B N/A
  • Earning Date
  • TOI 05-14-2025
  • HFRO^B N/A
  • Dividend Yield
  • TOI N/A
  • HFRO^B N/A
  • EPS Growth
  • TOI N/A
  • HFRO^B N/A
  • EPS
  • TOI N/A
  • HFRO^B N/A
  • Revenue
  • TOI $403,152,000.00
  • HFRO^B N/A
  • Revenue This Year
  • TOI $23.95
  • HFRO^B N/A
  • Revenue Next Year
  • TOI N/A
  • HFRO^B N/A
  • P/E Ratio
  • TOI N/A
  • HFRO^B N/A
  • Revenue Growth
  • TOI 17.64
  • HFRO^B N/A
  • 52 Week Low
  • TOI $0.13
  • HFRO^B N/A
  • 52 Week High
  • TOI $3.50
  • HFRO^B N/A
  • Technical
  • Relative Strength Index (RSI)
  • TOI 61.85
  • HFRO^B N/A
  • Support Level
  • TOI $2.82
  • HFRO^B N/A
  • Resistance Level
  • TOI $3.35
  • HFRO^B N/A
  • Average True Range (ATR)
  • TOI 0.37
  • HFRO^B 0.00
  • MACD
  • TOI -0.00
  • HFRO^B 0.00
  • Stochastic Oscillator
  • TOI 85.32
  • HFRO^B 0.00

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: